BioAsia 2013 : The Global Biobusiness Forum CCSwipe

BioAsia 2013 : The Global Biobusiness Forum CCSwipe

 

  • VVIP

    Sale Date Ended

    INR 75263
    Sold Out
  • Regular Registration for Conference

    Sale Date Ended

    INR 10000
    Sold Out
  • Early Bird Registration for Conference

    Sale Date Ended

    INR 8500
    Sold Out
  • Early Bird Registration for Private Equity Workshop

    Sale Date Ended

    INR 8500
    Sold Out
  • Regular Registration for Private Equity Workshop

    Sale Date Ended

    INR 10000
    Sold Out
  • Early Bird Registration for Conference and Private Equity Workshop

    Sale Date Ended

    INR 13600
    Sold Out
  • Regular Registration for Conference and Private Equity Workshop

    Sale Date Ended

    INR 16000
    Sold Out
  • Student Registration ( Full Conference Access)

    Sale Date Ended

    INR 4500
    Sold Out
  • Scientist / Faculty ( Full Conference Access)

    Sale Date Ended

    INR 7865
    Sold Out
  • Regular Registration for IP Master Class

    Sale Date Ended

    INR 5000
    Sold Out
  • Regular Registration for Conference and IP Master Class

    Sale Date Ended

    INR 11000
    Sold Out
  • Regular Registration for Master Class on Entrepreneurship in Life sciences

    Sale Date Ended

    INR 5000
    Sold Out
  • Regular Registration for Conference and Master Class on Entrepreneurship in Life sciences

    Sale Date Ended

    INR 11000
    Sold Out

Invite friends

Contact Us

Page Views : 90

About The Event

 

OFFLINE REGISTRATIONS(Coming Soon)

Entitlements:

Conference Registrations:

  • Entry on all the days to the plenary lectures and panel discussions
  • Access to Business partnering and International Tradeshow
  • Access to the buyer-seller meet
  • Invitation to the Inaugural ceremony and Valedictory Ceremony
  • BioAsia 2013 kit bag & lunch and refreshments for all the conference days

 Workshop Registrations:

  • Access to the registered workshop
  • Copy of the workshop resource materials
  • Lunch and refreshments during the workshop

 Conference + Workshop Registrations:

  • Entry on all the days to the plenary lectures and panel discussions.
  • Access to Business partnering and International Tradeshow
  • Access to the buyer-seller meet
  • Invitation to the Inaugural ceremony and Valedictory Ceremony
  • BioAsia 2013 kit bag & lunch and refreshments for all the conference days
  • Access to the registered workshop
  • Copy of the workshop resource materials
  • Lunch and refreshments during the workshop
BioAsia 2013 – Conference Agenda
January 28, 2013
09:00-16:00 Hrs Workshops and BioPark Visit (Separate Registrations)
17:00-18:00 Hrs Inaugural Ceremony
18:00-19:00 Hrs Keynote Address Trends in Global BioPharma R&D – Dr. Freda Lewis-Hall, Chief Medical Officer – Worldwide, Pfizer, USA
19:00-20:30 Hrs Welcome Reception
January 29, 2013
09:30-10:15 Hrs Keynote LectureDr. Bahija Jallal, Executive Vice President, Research & Development, MedImmune, USA*
10:15-11:45 Hrs Biologics and Biosimilars: Succeeding in the market of the future
  • Current state of the Biologics and Biosimilars market, including mAbs.
  • Weighing Needs and Costs
  • Are the next Block buster’s coming from Biologics
  Panelists:
  • Dr. Subir Basak, President (Global Discovery), Jubilant Lifesciences
  • Dr. Rajesh Ullanat, AVP & Head of Global Tech Development – Biologics, Mylan Pharmaceuticals*
  • Mr. Melt Van Der Spuy, Chairman & Managing Director, Eli Lilly & Company (India) Pvt. Ltd*
  • Dr. Himanshu Gadgill, Head – R&D, Intas Biopharmaceuticals Ltd.
  • Mr. Sachin Joshi, GM Bioprocess, GE Healthcare Pvt. Ltd.
  • Moderator - Mr. Jasmin Patel, Venture Partner, Aarin Capital
 
11:45-12:15 Hrs Speed Networking (Coffee / Tea Break)
12:15-13:45 Hrs Biomedical Research and Regulatory Environment
  • Fostering Biomedical Research in India
  • Recent Biosimilar guidelines of Government of India
  • US FDA's recent Guidance and it's impact
  Lead Speaker: Mr. Solomon Yimam, Asst. Country Director(Clinical Research), US FDA India   Panelists:
  • Mr. Satish Reddy, Managing Director & COO, Dr. Reddy’s Laboratories, India*
  • Mr. Ravi Penmetsa, Managing Director, Gland Pharma
  • Dr AKS Bhujanga Rao, President (R&D and Technical), Natco Pharma*
  • Moderator – Mr. Vikas Dandekar,  India Bureau Chief, Elsevier Business Intelligence
 
13:45-15:00 Hrs Lunch and Visit to the exhibition
15:00-16:30 Hrs Role of Emerging Markets in global biologics arena: Would India dominate 'Biosimilars'?
  • Challenges to Biologics and Biosimilars research especially in Asia
  • Is India ready to take a lead in Biosimilars /bio-better like it did in small molecules generics /branded generics?
  Lead Speaker: Dr. Salomon Azoulay, SVP Medical & Development Emerging Markets, Pfizer   Panelists:
  • Mr. Baoping Wang, Head, Novo Nordisk, China
  • Dr. Alex Kudrin, Medical Assessor, Biological Licensing Division, MHRA, UK
  • Mr. KV Subramaniam, President & CEO, Reliance Lifesciences
  • Moderator - Mr. Mike Ward, Editor-in-Chief, Scrip Intelligence, UK
 
16:30-18:00 Hrs Increasing Partnerships between Biologics Innovators and Biosimilars manufacturers
  • Commonalities and differences between global cos and local firms
  • Bridging the innovation gap
  • Case studies
  Lead Speaker: Dr. Shyam Bishen, Head, Emerging Markets Strategy & Commercial Development, Merck & Co.   Panelists:
  • Dr. Abhijit Barve, President – R&D, Biocon Ltd.*
  • Mr. C Bhaktavatsala Rao, Managing Director, Hospira Healthcare
  • Mr. C.L. Rathi, Managing Director, Advanced Enzymes
  • Moderator – Mr. Mahadevan Narayanamoni, Partner - Corporate Finance, Healthcare & Life Sciences Leader, Grant Thornton
 
18:30-21:00 Hrs CEO Conclave (Only by Invitation)
January 30, 2013
09:30-10:15 Hrs Keynote Lecture – Dr. Sridaran Natesan, Vice President- External Innovation (R&D), Science Strategy & Policy, Sanofi 
10:15-11:45 Hrs Is Biologics and Biosimilars a not-to-miss opportunity? – Overall perspective.   Panelists:
  • Dr. Ajit Shetty, VP Worldwide Operations, Johnson & Johnson & Chairman, Board of Directors, Janssen Pharmaceutica, Belgium
  • Dr. Rustom Mody, Sr. Vice President – Head R&D, Biotechnology Division - Lupin Ltd.
  • Dr. Charu Manaktala, Medical Director, Quintiles India
  • Mr. Anand Iyer, Head of Biotech Division, Strides Arcolabs Ltd.
  • Moderator - Mr. Aluri Srinivas Rao, Head – PE, Morgan Stanley PE
11:45-12:15 Hrs Speed Networking (Coffee / Tea Break)
12:15-13:45 Hrs Next Big Trends in Healthcare
  • Regenerative Medicine & Stem Cells
  Chair: Dr. Vishwa Mohan Katoch,  Secretary to Government of India, Department of Health Research, Ministry of Health & Family Welfare & Director General, Indian Council of Medial Research*   Panelists:
  • Dr. D. Balasubramainam, Director Research, L. V. Prasad Eye Institute
  • Shri Sreeshan Raghavan, Joint Secretary, Department of Biotechnology, Govt. of India*
  • Dr. Mohan C. Vemuri, Director – Stem Cells, Life Technologies*
  • Dr. Dave Smith, Head, Cell Therapy, Lonza
  • Canadian FDA Representative*
 
13:45-15:00 Hrs Lunch & Visit to Exhibitions
15:00-16:30 Hrs Fostering Industry – Academia Linkages in Bio-Medical R&D
  • Missing Links and opportunities
  • Creating IP Ecosystem
  Lead Speaker: Dr. W. Selvamurthy, Distinguished Scientist & Chief Controller R&D, DRDO   Panelists:
  • Prof. Lam Kong Peng, Director, Bio-Processing Technology Institute, A-Star, Singapore
  • Mr. Vinod Kuberkar, Managing Director, VTK Lifesciences Advisory Services / Western Range Biopharmaceuticals Pvt. Ltd.
  • Dr. Taslimarif Saiyed, Director and COO, Centre for Cellular and Molecular Platforms, NCBS-TIFR, Bangalore
 
16:30 – 17:00 Hrs Regulators’ Meet
17:00 Hrs Valedictory Ceremony & Close

Venue Map